—Mkt Cap: —P/E: —
MultiQure S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use. Its therapeutic portfolio in the field of immuno-oncology includes PB003G,…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap—
Enterprise Value13.80M $
Revenue (TTM)—
Gross Profit-7.34K $
Net Income (TTM)-2.49M $
Revenue/Share—
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLPRBLG00010
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-8.35
EV/Revenue—
P/S—
P/B—
EPS (TTM)-1.68
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE69.41%
ROA-198.79%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.58M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt3.91M $
Net Debt/EBITDA-2.36
Balance Sheet
Debt/Equity-1.13
Current Ratio0.09
Quick Ratio0.08
Book Value/Sh—
Cash/Share0.0830 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.12.24M
Float10.70M
Insiders1.38%
Institutions0.03%
Technical
SMA 502.369 PLN
SMA 2003.068 PLN
Beta0.21
S&P 52W Chg20.80%
Avg Vol (30d)—
Avg Vol (10d)670.79K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—